Form D — TriSalus Life Sciences, Inc.
0001231919-25-000045 · filed May 8, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $22,000,000
- Reported amount sold
- $22,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- TriSalus Life Sciences, Inc.
- CIK
- 1826667
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 6272 WEST 91ST AVENUE
WESTMINSTER, Colorado 80031 - Phone
- 415 336 8917
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Sean Murphy · DirectorWestminster, Colorado Find on LinkedIn ↗
-
Mary Szela · Executive OfficerWestminster, Colorado Find on LinkedIn ↗
-
James Young · Executive OfficerWestminster, Colorado Find on LinkedIn ↗
-
William F. Valle · DirectorWestminster, Colorado Find on LinkedIn ↗
-
Arjun Desai · DirectorWestminster, Colorado Find on LinkedIn ↗
-
Andrew von Eschenbach · DirectorWestminster, Colorado Find on LinkedIn ↗
-
Kerry Hicks · DirectorWestminster, Colorado Find on LinkedIn ↗
-
Gary Gordon · DirectorWestminster, Colorado Find on LinkedIn ↗
-
Brian Cox · Executive OfficerWestminster, Colorado Find on LinkedIn ↗
-
David J. Matlin · DirectorWestminster, Colorado Find on LinkedIn ↗
-
Mats Wahlstrom · DirectorWestminster, Colorado Find on LinkedIn ↗
-
Richard Marshak · Executive OfficerWestminster, Colorado Find on LinkedIn ↗
-
Jennifer Stevens · Executive OfficerWestminster, Colorado Find on LinkedIn ↗
-
Jodi Devlin · Executive OfficerWestminster, Colorado Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗